Kames Capital Plc Has Upped Starwood Property Trust (STWD) Stake By $4.39 Million; J Goldman & Company LP Increased Its Ptc Therapeutics (PTCT) Stake

May 26, 2018 - By Marguerite Chambers

PTC Therapeutics, Inc. (NASDAQ:PTCT) Logo

Kames Capital Plc increased Starwood Property Trust Inc (STWD) stake by 73.87% reported in 2017Q4 SEC filing. Kames Capital Plc acquired 209,265 shares as Starwood Property Trust Inc (STWD)’s stock declined 2.39%. The Kames Capital Plc holds 492,540 shares with $10.52 million value, up from 283,275 last quarter. Starwood Property Trust Inc now has $5.70B valuation. The stock decreased 0.18% or $0.04 during the last trading session, reaching $21.77. About 1.24M shares traded. Starwood Property Trust, Inc. (NYSE:STWD) has declined 7.26% since May 26, 2017 and is downtrending. It has underperformed by 18.81% the S&P500.

J Goldman & Company Lp increased Ptc Therapeutics Inc (PTCT) stake by 13799.66% reported in 2017Q4 SEC filing. J Goldman & Company Lp acquired 648,584 shares as Ptc Therapeutics Inc (PTCT)’s stock rose 91.83%. The J Goldman & Company Lp holds 653,284 shares with $10.90 million value, up from 4,700 last quarter. Ptc Therapeutics Inc now has $1.43B valuation. The stock increased 2.63% or $0.79 during the last trading session, reaching $30.8. About 540,777 shares traded. PTC Therapeutics, Inc. (NASDAQ:PTCT) has risen 274.65% since May 26, 2017 and is uptrending. It has outperformed by 263.10% the S&P500.

Among 12 analysts covering PTC Therapeutics (NASDAQ:PTCT), 4 have Buy rating, 2 Sell and 6 Hold. Therefore 33% are positive. PTC Therapeutics had 40 analyst reports since July 31, 2015 according to SRatingsIntel. The firm has “Outperform” rating by Credit Suisse given on Monday, November 14. The rating was downgraded by JP Morgan to “Neutral” on Tuesday, February 23. On Thursday, November 16 the stock rating was upgraded by J.P. Morgan to “Hold”. The stock of PTC Therapeutics, Inc. (NASDAQ:PTCT) earned “Hold” rating by RBC Capital Markets on Monday, January 29. The firm earned “Buy” rating on Thursday, February 22 by Citigroup. The stock of PTC Therapeutics, Inc. (NASDAQ:PTCT) earned “Outperform” rating by RBC Capital Markets on Friday, July 31. RBC Capital Markets maintained PTC Therapeutics, Inc. (NASDAQ:PTCT) on Friday, October 16 with “Outperform” rating. RBC Capital Markets maintained it with “Hold” rating and $1500 target in Wednesday, August 9 report. The rating was maintained by Oppenheimer on Thursday, February 25 with “Outperform”. RBC Capital Markets maintained the shares of PTCT in report on Thursday, September 14 with “Hold” rating.

Investors sentiment decreased to 0.98 in 2017 Q4. Its down 0.73, from 1.71 in 2017Q3. It dived, as 23 investors sold PTCT shares while 35 reduced holdings. 23 funds opened positions while 34 raised stakes. 35.45 million shares or 7.80% more from 32.89 million shares in 2017Q3 were reported. Federated Pa holds 0% or 1,005 shares in its portfolio. Parametric Portfolio Associate reported 27,120 shares. Hudson Bay Cap Management Ltd Partnership invested 0.02% of its portfolio in PTC Therapeutics, Inc. (NASDAQ:PTCT). The New Jersey-based Jacobs Levy Equity Mngmt has invested 0% in PTC Therapeutics, Inc. (NASDAQ:PTCT). Creative Planning has 14,021 shares. Morgan Stanley, New York-based fund reported 133,047 shares. Matarin Cap Management Limited Com stated it has 16,587 shares. Blackrock reported 3.09M shares stake. Guggenheim holds 0% of its portfolio in PTC Therapeutics, Inc. (NASDAQ:PTCT) for 86,908 shares. Macquarie Gp Limited accumulated 600 shares. Chicago Equity owns 17,770 shares or 0.01% of their US portfolio. Frontier Mngmt Lc owns 0.01% invested in PTC Therapeutics, Inc. (NASDAQ:PTCT) for 105,205 shares. New York-based Quantbot Technologies Lp has invested 0% in PTC Therapeutics, Inc. (NASDAQ:PTCT). Goldman Sachs Group Inc Inc reported 796,518 shares stake. Ameritas Inv Prns invested in 3,416 shares.

Another recent and important PTC Therapeutics, Inc. (NASDAQ:PTCT) news was published by Nasdaq.com which published an article titled: “Analysis: Positioning to Benefit within Entergy, Schneider National, CH Robinson Worldwide, PTC Therapeutics, Guess …” on May 09, 2018.

Since January 3, 2018, it had 0 insider buys, and 4 selling transactions for $61,523 activity. 412 shares were sold by Utter Christine Marie, worth $7,280 on Wednesday, January 3. 703 shares were sold by Almstead Neil Gregory, worth $12,675. Another trade for 2,230 shares valued at $40,207 was sold by Peltz Stuart Walter.

J Goldman & Company Lp decreased Therapeuticsmd Inc (NYSEMKT:TXMD) stake by 227,106 shares to 587,394 valued at $3.55 million in 2017Q4. It also reduced Potash Corp Sask Inc (Put) (NYSE:POT) stake by 1.18 million shares and now owns 75,000 shares. Eldorado Resorts Inc (NASDAQ:ERI) was reduced too.

Investors sentiment increased to 1.41 in 2017 Q4. Its up 0.32, from 1.09 in 2017Q3. It improved, as 35 investors sold STWD shares while 84 reduced holdings. 59 funds opened positions while 109 raised stakes. 171.72 million shares or 20.77% less from 216.73 million shares in 2017Q3 were reported. New York-based Tiaa Cref Investment Mgmt Ltd Llc has invested 0.01% in Starwood Property Trust, Inc. (NYSE:STWD). Rafferty Asset Mngmt Ltd Limited Liability Company holds 55,656 shares. Allsquare Wealth Ltd Liability Corp holds 0.02% or 1,279 shares. Old West Invest Management Lc reported 0.9% in Starwood Property Trust, Inc. (NYSE:STWD). State Common Retirement Fund invested in 0.01% or 563,500 shares. Massachusetts Financial Service Company Ma has 0.03% invested in Starwood Property Trust, Inc. (NYSE:STWD). Tudor Corp Et Al has invested 0.02% in Starwood Property Trust, Inc. (NYSE:STWD). Thompson Siegel Walmsley Ltd Llc has invested 0.03% in Starwood Property Trust, Inc. (NYSE:STWD). Regions Fincl Corp has 0% invested in Starwood Property Trust, Inc. (NYSE:STWD) for 14,821 shares. Advantus Mngmt Inc holds 0.07% in Starwood Property Trust, Inc. (NYSE:STWD) or 136,300 shares. Asset Mgmt has 9,385 shares. Ares Management Lc holds 0.14% of its portfolio in Starwood Property Trust, Inc. (NYSE:STWD) for 208,400 shares. Point72 Asia (Hong Kong) Limited has invested 0% in Starwood Property Trust, Inc. (NYSE:STWD). Bell State Bank holds 102,966 shares or 0.62% of its portfolio. Vanguard Group Inc has invested 0.02% in Starwood Property Trust, Inc. (NYSE:STWD).

More recent Starwood Property Trust, Inc. (NYSE:STWD) news were published by: Seekingalpha.com which released: “Starwood Property Trust’s (STWD) CEO Barry Sternlicht on Q1 2018 Results – Earnings Call Transcript” on May 04, 2018. Also Seekingalpha.com published the news titled: “Starwood Property Trust: Strong Q1 Results And Cheap Valuation Scream For A Buy” on May 05, 2018. Investorplace.com‘s news article titled: “3 High-Yield Dividend Stocks You Probably Overlooked” with publication date: May 02, 2018 was also an interesting one.

Starwood Property Trust, Inc. (NYSE:STWD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>